CDC & WHO STI Guidelines update 2022-CDC & WHO STI Guidelines update 2022

Video Transcription

Video Summary

The video provides an update on the 2022 guidelines for sexually transmitted infection (STI) testing, prophylaxis, and treatment. It emphasizes the increasing resistance of bacteria causing STIs, such as gonorrhea and chlamydia, to current antibiotic treatments. The CDC and WHO have revised testing methods to improve detection and treatment for STIs. <br /><br />The most prevalent STIs mentioned are chlamydia, HPV, trichomonas, herpes simplex virus (HSV), gonorrhea, syphilis, HIV, hepatitis B, hepatitis C, and human papillomavirus (HPV). The video provides information on the prevalence, transmission, clinical manifestations, testing, and treatment for each of these infections. It also discusses the importance of STI testing following sexual assault and offers recommendations for prophylaxis and treatment in children, adolescents, and adults. The CDC and WHO guidelines for the treatment of STIs are provided, along with considerations for testing and treatment limitations in low-income and middle-income countries. The video concludes with references used in the presentation and contact information for further questions.

Keywords

2022 guidelines

STI testing

bacteria resistance

gonorrhea

chlamydia

revised methods

prevalent STIs

sexual assault

prophylaxis